Abstract
Background
Little is known about the relationships between pregnancy cravings, maternal diet, and development of abnormal glucose tolerance.
Objectives
We examined relationships of pregnancy cravings with dietary intake and risk of developing isolated hyperglycemia (IH), impaired glucose tolerance (IGT), or gestational diabetes (GDM) later in pregnancy.
Design/Setting
Among 2,022 mothers in Project Viva, a prospective birth cohort recruited from medical practices in Eastern Massachusetts between 1999 and 2002, we assessed type of pregnancy craving based on self-report at mean 10.9 weeks gestation.
Main Outcome Measures
The outcomes were cross-sectional dietary intake from a food frequency questionnaire and incident IH, IGT, or GDM determined by glucose tolerance screening at 26–28 weeks.
Statistical Analyses Performed
We used linear regression to analyze the cross-sectional relationships between pregnancy cravings and dietary intake and multinomial logistic regression to analyze the prospective relationships between pregnancy cravings and development of IH, IGT, or GDM.
Results
During the first trimester, 443 (22%) women craved sweets, 225 (11%) craved salty foods, 261 (13%) craved savory foods, and 100 (4.9%) craved starchy foods. Sweet cravings were associated with increased intake of sucrose (1.9 gm/day 95% CI:0.1, 3.7), total fat (1.5 gm/day 95% CI:0.1, 2.9), and saturated fat (0.8 gm/day 95% CI:0.2, 1.4); salty cravings with increased fiber (0.7 95% CI: −0.1, 1.6); savory cravings with increased N-3 fatty acids (0.10 gm/day 95% CI:0.02, 0.17); and starchy cravings with increased carbohydrates (8.0 gm/day 95% CI:0.3, 15.7) and decreased total fat (−2.6 gm/day 95% CI: −5.2, −0.1). Salty cravings were associated with lower risk of GDM (adjusted OR:0.34 95% CI:0.12, 0.97).
Conclusion
New cravings in the first trimester of pregnancy were associated with dietary intake. Craving salty foods may predict reduced risk of developing GDM, while craving sweet food does not appear to alter ones risk.
Keywords: diet, maternal diet, gestational diabetes, pregnancy cravings, abnormal glucose tolerance
Introduction/Background
Experiencing cravings for specific foods or types of food is common during pregnancy. Approximately 45–90% of women in the United States report experiencing new cravings sometime during pregnancy.1–3 While there are different regional and cultural theories about pregnancy cravings and their relationship to gestational outcomes, there is little understanding of the correlates and outcomes related to such cravings.
Gestational diabetes (GDM) affects approximately 4–7% of pregnant women in the United States.4,5 GDM can have harmful effects for both the mother and fetus, including increasing the risk of pregnancy complications, preeclampsia, emergency cesarean section, macrosomia, and asphyxia.6–8 Even milder forms of abnormal glucose tolerance such as impaired glucose tolerance (IGT), are associated with increased health risks of macrosomia, toxemia, and emergency cesarean section.9–11 The causes for GDM are multifaceted; the most important is higher weight status, but dietary intake of saturated fat or dietary fiber, limited physical activity, smoking during pregnancy, and family history may also increase risk.12–14
In studies from one group of authors, GDM was associated with subsequent decreased taste perception of sweet foods and increased craving for sweet food.4,5 Tepper4 found an exaggerated preference for sweetened dairy drinks in women with GDM compared to healthy women. This preference seemed to emerge during the third trimester of pregnancy (weeks 34–38).4 Later research found women with GDM were twice as likely as normal glucose tolerant women to crave sweet food at 34–38 weeks gestation.5 While these studies suggest a relationship between sweet cravings and GDM, the diagnosis of GDM preceded the measurement of the craving in most of them, whereas it is equally interesting to ask whether preexisting cravings reflect a biologic-state of increased risk to develop abnormal glucose tolerance. In one study, Belzer et al. did measure cravings prospectively starting at 16–20 weeks’ gestation, but found little evidence of cravings related to GDM until the 3rd trimester, after the GDM diagnosis.5
One possible mechanism by which cravings could influence GDM risk is through changes in diet. However, clear nutrient or diet patterns predicting GDM diagnosis have not been consistently replicated across studies. In the Project Viva cohort, Radesky et al. found a relationship between increased N-3 fatty acid intake in early pregnancy but no associations between many other foods or nutrients, with subsequent GDM diagnosis.15 In contrast in a case-control study, Bo et al., found higher early pregnancy saturated fat intake to be associated with risk of GDM/IGT.12 Moses et al. and Zhang et al. found prospective and cross-sectional correlations between increased dietary fiber intake and reduced risk of GDM.14,16
The objectives of this paper were to assess associations of new cravings during pregnancy with contemporaneous food and nutrient intakes, and with subsequent development of abnormal glucose tolerance. We hypothesized that cravings for sweet foods in early pregnancy would be associated with increased intake of sweet foods and with risk for abnormal glucose tolerance.
Materials and Methods
We based our analysis on participating mothers in the Project Viva pre-birth cohort. Other publications have described the recruitment and retention procedures.17–19 In summary, Project Viva recruited pregnant women during their initial obstetric care visit between 1999 and 2002 at one of eight obstetrical offices of Harvard Vanguard Medical Associations, a multispecialty group practice located in eastern Massachusetts.
Women were eligible for participation if they could complete the study forms in English, had a singleton pregnancy, had no plans to move before delivery, and presented for their initial care visit before 22 weeks’ gestation. We collected data through interviews, self-administered questionnaires, examinations, and electronic medical records. The authors have obtained both informed consent and ethics committee approval for studies on patients. This analysis was approved by the institutional review board at Harvard Pilgrim Health Care.
There were 2,128 live singleton births within the Project Viva cohort. For this analysis, we excluded women who denied permission to use medical records (n=25), with deliveries with no information on the glucose tolerance (n=36) and no information on cravings during early pregnancy (n=45), leaving 2,022 women for analysis.
Pregnancy Cravings Assessment
Mothers in the Project Viva cohort completed first trimester interviews at mean +/− SD 10.9 +/− 2.3 weeks gestation. Interviewers asked participants whether or not they had any new cravings for a particular food or beverage during this pregnancy. If participants answered yes, we asked them to list what new cravings they had experienced in an open-ended question. We created six categories for cravings: sweet, salty, savory, starchy, non-sweet dairy and other based on prior literature on the topic.5 We put each food craving into one or more of the six categories. We assigned craving categories for each food: ‘primary’ for the category that is the primary or majority taste component of the food; ‘secondary’ for any other category that is not the main taste component of the food; and ‘none’ for craving categories not associated with the food. The lead author created these categories; for the ~25% of foods with ambiguous categorizations, all 3 authors discussed them to arrive at consensus. Table 1 shows all six categories of cravings, with examples of food with ‘primary’ status in each category. Table 2 shows examples of how we categorized cravings for specific foods into ‘primary’ (1), ‘secondary’ (2) and ‘none’ (0). For analysis, we collapsed ‘secondary’ and ‘none,’ and thus compared primary v. secondary/none in relation to the outcomes.
Table 1.
Sweet | Candy, cakes, cookies, fruit, fruit juice, pastries, sweetened cereal, sweetened milk, ice cream, frozen yogurt, pie, pudding, smoothies |
Salty | Chips, crackers, pretzels, soup, pickles, French fries, fried food, popcorn, macaroni and cheese, peanut butter |
Savory | Eggs, meat, mixed dishes, seafood |
Starchy | Bread, non-fried potatoes, rice, pasta |
Non-sweet dairy | Milk, cheese, plain yogurt |
Other | Vegetables, water, ice |
Table 2.
Sweet | Salty | Savory | Starchy | Non-sweet Dairy | Other | |
---|---|---|---|---|---|---|
Candy bar | 1 | 0 | 0 | 0 | 0 | 0 |
French fries | 0 | 1 | 0 | 1 | 0 | 0 |
Broccoli | 0 | 0 | 0 | 0 | 0 | 1 |
Chicken Soup | 0 | 1 | 2 | 0 | 0 | 0 |
Cake | 1 | 0 | 0 | 2 | 0 | 0 |
Mexican Food | 0 | 2 | 2 | 2 | 2 | 0 |
Dietary Assessment
After the early pregnancy interview we sent each woman home with questionnaires to complete. At mean 11.8 weeks gestation mothers in Project Viva completed a self-administered food frequency questionnaire (FFQ), which was modified for use during pregnancy from the FFQ used in the Nurses’ Health Study, and validated within this study population for several nutrients.20 We asked women to report frequency of consumption of over 140 specific food and beverages during this pregnancy, defined as “since your last menstrual period until now.” To determine nutrient intake, we multiplied a weight assigned to the frequency of use by nutrient composition for the portion size pre-specified for each food. To estimate nutrient content, we used the Harvard nutrient composition database.21
Glucose tolerance outcomes
Mothers in Project Viva were screened by their prenatal providers for gestational diabetes between 26–28 weeks gestation, initially with a non-fasting oral glucose challenge. Participants were given 50 grams of oral glucose and venous blood was sampled one hour afterwards. A blood glucose level of ≥ 140 mg/dL prompted a referral for a 3-hour fasting 100-g oral glucose tolerance test. The participant’s blood glucose was measured at baseline and once an hour for 3 hours after the glucose load. Normal blood glucose levels were <95 mg/dL at baseline, <180 mg/dL after 1 hour, <155 mg/dL after 2 hours and <140 mg/dL after three hours. We defined participants as normal if they were <140 mg/dL on the non-fasting oral glucose challenge, and having isolated hyperglycemia (IH) if they had a blood glucose level ≥140 on the non-fasting oral glucose challenge, but had no abnormal results on the glucose tolerance test. We defined participants as having impaired glucose tolerance (IGT) if they had one abnormal result on the glucose tolerance test, and gestational diabetes (GDM) if they had two or more abnormal results.
Statistical Analysis
We used linear regression to analyze the cross-sectional relationships between pregnancy cravings and dietary intake. Pre-specified nutrient outcomes included total energy, carbohydrates, sucrose, glucose, fructose, lactose, glycemic load, total fat, saturated fat, monounsaturated fat, trans fat, polyunsaturated fat, N-3 fatty acids, N-6 fatty acids protein, calcium and dietary fiber. Foods included cereals/breads and starches, and vegetables. The one dietary pattern we analyzed was fried food eaten away from home.
In multivariable adjusted models we included covariates we considered a priori to potentially be related to cravings and dietary intake, including maternal pre-pregnancy body mass index (BMI), age, race/ethnicity (white/black/Hispanic/other), education (college graduate yes/no), smoking during pregnancy and GDM in a previous pregnancy. We did not include the following potential confounders because adding them to the model did not change effect estimates by > 10%: parity, physical activity and TV watching during pregnancy, and presence of nausea and/or vomiting. We energy-adjusted all nutrients via the residuals method.22
We used multinomial logistic regression to analyze the prospective relationships between pregnancy cravings and development of abnormal glucose tolerance diagnosis, with normal glucose tolerance as the referent. We included the same covariates as in the analysis of cravings and dietary intake.
Results
Among the 2,022 participants, mean +/− SD age was 31.8 +/− 5.2 years and mean pre-pregnancy BMI was 24.9 +/− 5.5 kg/m2. A minority of participants 662 (33%) women identified as non-white. In the 1st trimester, 907 (45%) women reported cravings; 443 (22%) craved sweets, 225 (11%) craved salty foods, 261 (13%) craved savory foods, and 100 (5%) craved starchy foods (Table 3). 117 (5.8%) women developed GDM, 63 (3.1%) developed IGT, and 179 (8.9%) developed IH (Table 3).
Table 3.
Any Cravings | Sweet | Salty | Savory | Starchy | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Total n=2022 |
No n=1115 |
Yes n=907 |
None/ Secondary n=1579 |
Primary n=443 |
None/ Secondary n=1797 |
Primary n=225 |
None/ Secondary n=1761 |
Primary n=261 |
None/ Secondary n=1922 |
Primary n=100 |
|
N (%) | |||||||||||
Race/ethnicity | |||||||||||
Black | 329 (16.3) | 158 (14.2) | 171 (18.9) | 244 (15.5) | 85 (19.2) | 285 (15.9) | 44 (19.6) | 272 (15.4) | 57 (21.8) | 316 (16.4) | 13 (13.0) |
Hispanic | 147 (7.3) | 76 (6.8) | 71 (7.8) | 111 (7.0) | 36 (8.1) | 135 (7.5) | 12 (5.3) | 119 (6.8) | 28 (10.7) | 138 (7.2) | 9 (9.0) |
Asian | 110 (5.4) | 74 (6.6) | 36 (4.0) | 97 (6.1) | 13 (2.9) | 99 (5.5) | 11 (4.9) | 102 (5.8) | 8 (3.1) | 106 (5.5) | 4 (4.0) |
White | 1360 (67.3) | 780 (70.0) | 580 (63.9) | 1081 (68.5) | 279 (63.0) | 1212 (67.4) | 148 (65.8) | 1206 (68.5) | 154 (59.0) | 1290 (67.1) | 70 (70.0) |
Other | 76 (3.8) | 27 (2.4) | 49 (5.4) | 46 (2.9) | 30 (6.8) | 66 (3.7) | 10 (4.4) | 62 (3.5) | 14 (5.4) | 72 (3.7) | 4 (4.0) |
College graduate | |||||||||||
No | 707 (35.0) | 365 (32.7) | 342 (37.7) | 533 (33.8) | 174 (39.3) | 633 (35.2) | 74 (32.9) | 591 (33.6) | 116 (44.4) | 676 (35.2) | 31 (31.0) |
Yes | 1315 (65.0) | 750 (67.3) | 565 (62.3) | 1046 (66.2) | 269 (60.7) | 1164 (64.8) | 151 (67.1) | 1170 (66.4) | 145 (55.6) | 1246 (64.8) | 69 (69.0) |
Married or cohabitating | |||||||||||
No | 170 (8.4) | 75 (6.7) | 95 (10.5) | 118 (7.5) | 52 (11.7) | 149 (8.3) | 21 (9.3) | 135 (7.7) | 35 (13.4) | 161 (8.4) | 9 (9.0) |
Yes | 1851 (91.6) | 1039 (93.3) | 812 (89.5) | 1460 (92.5) | 391 (88.3) | 1647 (91.7) | 204 (90.7) | 1625 (92.3) | 226 (86.6) | 1760 (91.6) | 91 (91.0) |
Smoking during pregnancy | |||||||||||
No | 1758 (87.5) | 982 (88.9) | 776 (85.8) | 1386 (88.4) | 372 (84.2) | 1566 (87.8) | 192 (85.3) | 1531 (87.5) | 227 (87.3) | 1666 (87.3) | 92 (92.0) |
Yes | 251 (12.5) | 123 (11.1) | 128 (14.2) | 181 (11.6) | 70 (15.8) | 218 (12.2) | 33 (14.7) | 218 (12.5) | 33 (12.7) | 243 (12.7) | 8 (8.0) |
Nausea for > 7 days | |||||||||||
No | 972 (48.2) | 576 (51.8) | 396 (43.7) | 785 (49.8) | 187 (42.2) | 885 (49.4) | 87 (38.7) | 856 (48.7) | 116 (44.4) | 942 (49.1) | 30 (30.3) |
Yes | 1046 (51.8) | 536 (48.2) | 510 (56.3) | 790 (50.2) | 256 (57.8) | 908 (50.6) | 138 (61.3) | 901 (51.3) | 145 (55.6) | 977 (50.9) | 69 (69.7) |
Parity | |||||||||||
0 | 972 (48.1) | 555 (49.8) | 417 (46.0) | 773 (49.0) | 199 (44.9) | 859 (47.8) | 113 (50.2) | 858 (48.7) | 114 (43.7) | 920 (47.9) | 52 (52.0) |
1–2 | 959 (47.4) | 512 (45.9) | 447 (49.3) | 734 (46.5) | 225 (50.8) | 853 (47.5) | 106 (47.1) | 826 (46.9) | 133 (51.0) | 914 (47.6) | 45 (45.0) |
3+ | 91 (4.5) | 48 (4.3) | 43 (4.7) | 72 (4.6) | 19 (4.3) | 85 (4.7) | 6 (2.7) | 77 (4.4) | 14 (5.4) | 88 (4.6) | 3 (3.0) |
Previous GDM | |||||||||||
No | 1979 (97.9) | 1091 (97.8) | 888 (98.0) | 1541 (97.7) | 438 (98.9) | 1755 (97.7) | 224 (99.6) | 1726 (98.1) | 253 (96.9) | 1880 (97.9) | 99 (99.0) |
Yes | 42 (2.1) | 24 (2.2) | 18 (2.0) | 37 (2.3) | 5 (1.1) | 41 (2.3) | 1 (0.4) | 34 (1.9) | 8 (3.1) | 41 (2.1) | 1 (1.0) |
Glucose category* | |||||||||||
Normal | 1663 (82.2) | 912 (81.8) | 751 (82.8) | 1308 (82.8) | 355 (80.1) | 1464 (81.5) | 199 (88.4) | 1442 (81.9) | 221 (84.7) | 1575 (81.9) | 88 (88.0) |
IH | 179 (8.9) | 98 (8.8) | 81 (8.9) | 135 (8.5) | 44 (9.9) | 162 (9.0) | 17 (7.6) | 160 (9.1) | 19 (7.3) | 173 (9.0) | 6 (6.0) |
IGT | 63 (3.1) | 35 (3.1) | 28 (3.1) | 46 (2.9) | 17 (3.8) | 58 (3.2) | 5 (2.2) | 56 (3.2) | 7 (2.7) | 60 (3.1) | 3 (3.0) |
GDM | 117 (5.8) | 70 (6.3) | 47 (5.2) | 90 (5.7) | 27 (6.1) | 113 (6.3) | 4 (1.8) | 103 (5.8) | 14 (5.4) | 114 (5.9) | 3 (3.0) |
Mean +/− SD | |||||||||||
Age, years | 31.8 +/− 5.2 | 32.1 +/− 4.9 | 31.5 +/− 5.6 | 31.9 +/− 5.1 | 31.5 +/− 5.6 | 31.9 +/− 5.1 | 30.9 +/− 6.1 | 31.9 +/− 5.1 | 31.1 +/− 5.8 | 31.9 +/− 5.2 | 31.3 +/− 5.7 |
BMI, kg/m2 | 24.9 +/− 5.5 | 24.9 +/− 5.5 | 24.9 +/− 5.5 | 24.8 +/− 5.4 | 25.2 +/− 5.8 | 24.9 +/− 5.5 | 24.2 +/− 5.5 | 24.9 +/− 5.5 | 24.9 +/− 5.4 | 24.9 +/− 5.5 | 23.6 +/− 4.6 |
IH- Isolated Hyperglycemia; IGT- Impaired glucose tolerance; GDM- gestational diabetes
Mean +/− SD total energy intake was 2061 +/− 674 kilocalories. Mean +/−SD intake (g/day) of carbohydrates was 277 +/−36, sucrose 49.5 +/−15.5, total fat 62.8 +/−12.1, saturated fat 23.4 +/−5.5, and N-3 fatty acids 1.13 +/−0.52; and glycemic load was 14759 +/−2274 (Supplemental Table 1).
In crude analysis, sweet cravings were associated with increased intake of sucrose (1.9 gm/day 95% CI 0.1, 3.7), total fat (1.5 gm/day 95% CI 0.1, 2.9), and saturated fat (0.8 gm/day 95% CI 0.2, 1.4); salty cravings were borderline associated with increased fiber (0.7 95% CI −0.1, 1.6) and decreased saturated fat (−0.6 95% CI−1.4, 0.2); savory cravings with increased N-3 fatty acids (0.10 gm/day 95% CI: 0.02, 0.17); and starchy cravings with increased carbohydrates (8.0 gm/day 95% CI 0.3, 15.7) and decreased total fat (−2.6 gm/day 95% CI −5.2, −0.1). In adjusted analysis, sweet cravings remained associated with increased saturated fat (0.7 gm/day 95% CI 0.1, 1.3), savory cravings with increased N-3 fatty acids (0.08 95% CI 0.01, 0.16), and starchy cravings with carbohydrates (7.6 95% CI 0.0, 15.2) and decreased total fat (−2.5 95% CI −5.1, 0.0) (Table 4).
Table 4.
Sweet | Salty | Savory | Starchy | |||||
---|---|---|---|---|---|---|---|---|
Nutrient | Crude | Adjusted* | Crude | Adjusted* | Crude | Adjusted* | Crude | Adjusted* |
Linear regression estimate (95% CI) | ||||||||
Carbohydrates(g/d) | −2.8 (−6.9, 1.4) | −2.4 (−6.5, 1.7) | 4.9 (−0.5, 10.2) | 3.8 (−1.4, 9.1) | −1.0 (−6.2, 4.3) | −1.0 (−6.2, 4.1) | 8.0 (0.3, 15.7) | 7.6 (0.0, 15.2) |
Sucrose (g/d) | 1.9 (0.1, 3.7) | 1.5 (−0.2, 3.2) | 0.9 (−1.4, 3.2) | 0.7 (−1.5, 2.9) | 0.7 (−1.6, 3.0) | 0.1 (−2.1, 2.3) | 2.0 (−1.4, 5.3) | 2.4 (−0.8, 5.6) |
Glycemic Load | −115 (−378,147) | −99 (−357,159) | 178 (−160,517) | 103 (−229,435) | −67 (−398,264) | −101 (−425,224) | 466 (−22,954) | 458 (−20,936) |
Total Fat (g/d) | 1.5 (0.1, 2.9) | 1.2 (−0.2, 2.6) | −1.5 (−3.3, 0.3) | −1.2 (−3.0, 0.6) | 0.7 (−1.1, 2.5) | 0.5 (−1.2, 2.2) | −2.6 (−5.2, −0.1) | −2.5 (−5.1, 0.0) |
Saturated Fat (g/d) | 0.8 (0.2, 1.4) | 0.7 (0.1, 1.3) | −0.6 (−1.4, 0.2) | −0.4 (−1.2, 0.4) | 0.3 (−0.5, 1.1) | 0.3 (−0.5, 1.0) | −0.9 (−2.1, 0.2) | −0.9 (−2.0, 0.3) |
N-3 Fatty Acids (g/d) | 0.03 (−0.03, 0.09) | 0.02 (−0.04, 0.08) | −0.07 (−0.15, 0.01) | −0.06 (−0.14, 0.02) | 0.10 (0.02, 0.17) | 0.08 (0.01, 0.16) | 0.01 (−0.11, 0.12) | 0.01 (−0.10, 0.13) |
Dietary Fiber (serv/d) | −0.5 (−1.1, 0.2) | −0.3 (−0.9, 0.4) | 0.7 (−0.1, 1.6) | 0.8 (−0.1, 1.6) | 0.2 (−0.7, 1.0) | 0.4 (−0.4, 1.2) | 0.3 (−0.9, 1.5) | 0.1 (−1.1, 1.3) |
Adjusted for age, race/ethnicity, education, smoking, pre-pregnancy BMI, and GDM in a previous pregnancy
Craving salty food was associated with lower risk of GDM (adjusted OR 0.34 95% CI 0.12, 0.97). Craving sweet, savory, or salty foods was not associated with abnormal glucose tolerance (Table 5).
Table 5.
Sweet | Salty | Savory | Starchy | |||||
---|---|---|---|---|---|---|---|---|
Glucose Tolerance Outcome | Crude | Adjusted* | Crude | Adjusted* | Crude | Adjusted* | Crude | Adjusted* |
Odds ratio (95% CI) | ||||||||
Normal | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) | 1.0 (ref) |
Isolated hyperglycemia | 1.20 (0.84, 1.72) | 1.26 (0.87, 1.82) | 0.77 (0.46, 1.30) | 0.85 (0.50, 1.44) | 0.77 (0.47, 1.27) | 0.81 (0.49, 1.34) | 0.62 (0.27, 1.44) | 0.65 (0.28, 1.53) |
IGT | 1.36 (0.77, 2.40) | 1.41 (0.79, 2.50) | 0.63 (0.25, 1.60) | 0.67 (0.27, 1.71) | 0.82 (0.37, 1.81) | 0.82 (0.36, 1.83) | 0.89 (0.28, 2.91) | 1.03 (0.31, 3.37) |
GDM | 1.11 (0.71, 1.73) | 1.37 (0.84, 2.23) | 0.26 (0.10, 0.71) | 0.34 (0.12, 0.97) | 0.89 (0.50, 1.58) | 0.76 (0.39, 1.49) | 0.47 (0.15, 1.51) | 0.62 (0.18, 2.14) |
Adjusted for age, race/ethnicity, education, smoking, pre-pregnancy BMI, and GDM in previous pregnancy
Discussion
Approximately 45% of the Project Viva participants in this analysis reported having new cravings for specific foods that started during pregnancy. This estimate is consistent with the other published studies on the prevalence of cravings in early pregnancy.1–3 Women tend to experience the largest number of new cravings during their third trimester, thus our study may underestimate of the total percentage of women experiencing cravings during the whole of pregnancy.5 Approximately 5.8% of women in this analysis developed GDM, with a total of 17.8% developing some kind of abnormal glucose tolerance (GDM, IGT, or IH).
In this study, new dietary cravings in early pregnancy were associated with higher intakes of several nutrients including sucrose, total fat, saturated fat, N-3 fatty acids, carbohydrate intake, and glycemic load. However, while statistically significant, these changes are of modest magnitude. We hypothesized some of these associations. For example, sweet cravings were associated with both increased sucrose and total fat intake. This result implies that those who have sweet cravings may indulge their cravings by eating foods high in fat and sucrose, which are traditional components of dessert foods in the Western diet. Starchy cravings were associated with increased carbohydrate intake and increased glycemic load, implying that women who have strong cravings for starchy foods eat increased amounts of carbohydrates, which typically have a high glycemic load. Other relationships are more challenging to explain, for example associations between savory cravings and N-3 fatty acids intake.
Craving type also predicted abnormal glucose tolerance outcomes. In the adjusted analysis, salty cravings predicted lower risk GDM. We had originally hypothesized that sweet cravings would predict later GDM diagnosis. However, we found no evidence that sweet, savory, or starchy cravings were associated with abnormal glucose tolerance. This finding is consistent with Belzer et al. which found that women who developed gestational diabetes did not experience more sweet and savory cravings early in pregnancy compared to women with normal glucose tolerance.5
Our data raise the possibility of a possible mechanism in which cravings predict dietary intake and dietary intake contributes to abnormal glucose tolerance. Bo et al. found that increased saturated fat intake in the first trimester was associated with risk of GDM later in pregnancy (OR: 2, 95% CI: 1.2–3.2).12 In this analysis we found salty cravings were associated with both decreased saturated fat intake and decreased odds of GDM, although in previous work we did not find that saturated fat intake predicted GDM in Project Viva.15
In another example, Zhang et al. and Moses et al. found dietary fiber intake to be associated with lower risk of GDM.14,16 Every additional 10 gm/day in total dietary fiber was associated with a 26% (95% CI: 9–49) reduction in risk of GDM.16 In our analysis salty foods were associated with both increased dietary fiber intake and reduced risk of GDM. As with saturated fat, however, in our previous work we did not find that dietary fiber intake during pregnancy was associated with GDM in Project Viva.15
Strengths and Limitations
Strengths of this analysis include its relatively large sample size, validated dietary assessment, and the prospective nature of the glucose tolerance outcome assessment. However, even with large overall sample size, low numbers of individuals in specific combinations of cravings and outcomes yielded wide confidence intervals.
Since Project Viva recruited women with health insurance, these results may not be generalizable to populations of lower socioeconomic status. Additionally, cravings for specific foods vary from culture to culture so the types and proportion of craving types may not be the same in other populations.
A challenge in this study was categorizing cravings for complex or mixed dishes, such as Mexican food (table 2). The complexity of categorizing complicated and mixed dishes may have led to non-differential misclassification and bias toward the null.
Conclusions
The main findings from our study are that cravings for salty food during pregnancy may be protective against later risk for abnormal glucose tolerance. Additionally, craving sweet food does not appear to alter ones risk. Further research is needed to confirm these findings and should investigate possible mechanisms between cravings during pregnancy with health outcomes, as well as implications for dietary clinical practice among pregnant women.
Supplementary Material
Acknowledgments
Sources of financial support: Research is supported by NIH grant: R37HD034568
Author has been partially supported through the Maternal and Child Bureau grant T76MC00001 and by Training Grant T32HD060454 in Reproductive, Perinatal and Pediatric Epidemiology from the National Institute of Child Health and Human Development, National Institutes of Health.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest:
Farland and Rifas-Shiman have no conflicts of interest to report.
Dr. Gillman receives royalties from Cambridge University Press as co-editor of the book Maternal Obesity, and also from UpToDate as the author of the chapter on dietary fat.
References
- 1.Pope JF, Skinner JD, Carruth BR. Cravings and aversions of pregnant adolescents. J Am Diet Assoc. 1992 Dec;92(12):1479–1482. [PubMed] [Google Scholar]
- 2.Wijewardene K, Fonseka P, Goonaratne C. Dietary cravings and aversions during pregnancy. Indian J Public Health. 1994 Jul-Sep;38(3):95–98. [PubMed] [Google Scholar]
- 3.Worthington-Roberts B, Little RE, Lambert MD, Wu R. Dietary cravings and aversions in the postpartum period. J Am Diet Assoc. 1989 May;89(5):647–651. [PubMed] [Google Scholar]
- 4.Tepper BJ, Seldner AC. Sweet taste and intake of sweet foods in normal pregnancy and pregnancy complicated by gestational diabetes mellitus. Am J Clin Nutr. 1999 Aug;70(2):277–284. doi: 10.1093/ajcn.70.2.277. [DOI] [PubMed] [Google Scholar]
- 5.Belzer LM, Smulian JC, Lu SE, Tepper BJ. Food cravings and intake of sweet foods in healthy pregnancy and mild gestational diabetes mellitus. A prospective study. Appetite. Dec;55(3):609–615. doi: 10.1016/j.appet.2010.09.014. [DOI] [PubMed] [Google Scholar]
- 6.Petrou S, Kupek E, Vause S, Maresh M. Antenatal visits and adverse perinatal outcomes: Results from a British population-based study. European Journal of Obstetrics Gynecology and Reproductive Biology. 2003;106(1):40–49. doi: 10.1016/s0301-2115(02)00215-4. [DOI] [PubMed] [Google Scholar]
- 7.Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care. 1998 Aug;21(Suppl 2):B79–84. [PubMed] [Google Scholar]
- 8.Yogev Y, Visser GH. Obesity, gestational diabetes and pregnancy outcome. Seminars in fetal & neonatal medicine. 2009 Apr;14(2):77–84. doi: 10.1016/j.siny.2008.09.002. [DOI] [PubMed] [Google Scholar]
- 9.Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R. Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med. 1986 Oct 16;315(16):989–992. doi: 10.1056/NEJM198610163151603. [DOI] [PubMed] [Google Scholar]
- 10.Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Molsted-Pedersen L, Damm P. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand. 2008;87(1):59–62. doi: 10.1080/00016340701823975. [DOI] [PubMed] [Google Scholar]
- 11.Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2005 Jan;17(1):29–34. doi: 10.1080/14767050400028766. [DOI] [PubMed] [Google Scholar]
- 12.Bo S, Menato G, Lezo A, et al. Dietary fat and gestational hyperglycaemia. Diabetologia. 2001 Aug;44(8):972–978. doi: 10.1007/s001250100590. [DOI] [PubMed] [Google Scholar]
- 13.Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997 Oct 1;278(13):1078–1083. [PubMed] [Google Scholar]
- 14.Moses RG, Shand JL, Tapsell LC. The recurrence of gestational diabetes: could dietary differences in fat intake be an explanation? Diabetes Care. 1997 Nov;20(11):1647–1650. doi: 10.2337/diacare.20.11.1647. [DOI] [PubMed] [Google Scholar]
- 15.Radesky JS, Oken E, Rifas-Shiman SL, Kleinman KP, Rich-Edwards JW, Gillman MW. Diet during early pregnancy and development of gestational diabetes. Paediatr Perinat Epidemiol. 2008 Jan;22(1):47–59. doi: 10.1111/j.1365-3016.2007.00899.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhang C, Liu S, Solomon CG, Hu FB. Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care. 2006 Oct;29(10):2223–2230. doi: 10.2337/dc06-0266. [DOI] [PubMed] [Google Scholar]
- 17.Gillman MW, Rich-Edwards JW, Rifas-Shiman SL, Lieberman ES, Kleinman KP, Lipshultz SE. Maternal age and other predictors of newborn blood pressure. J Pediatr. 2004 Feb;144(2):240–245. doi: 10.1016/j.jpeds.2003.10.064. [DOI] [PubMed] [Google Scholar]
- 18.Oken E, Kleinman KP, Olsen SF, Rich-Edwards JW, Gillman MW. Associations of seafood and elongated n-3 fatty acid intake with fetal growth and length of gestation: results from a US pregnancy cohort. Am J Epidemiol. 2004 Oct 15;160(8):774–783. doi: 10.1093/aje/kwh282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Oken E, Baccarelli AA, Gold DR, et al. Cohort profile: project viva. Int J Epidemiol. 2015 Feb;44(1):37–48. doi: 10.1093/ije/dyu008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fawzi WW, Rifas-Shiman SL, Rich-Edwards JW, Willett WC, Gillman MW. Calibration of a semi-quantitative food frequency questionnaire in early pregnancy. Ann Epidemiol. 2004 Nov;14(10):754–762. doi: 10.1016/j.annepidem.2004.03.001. [DOI] [PubMed] [Google Scholar]
- 21.US Department of Agriculture ARS. USDA Nutrient Database for Standard Reference, Release 13. http://www.ars.usda.gov/ba/bhnrc/ndl. Accessed 1999.
- 22.Willett WC. Nutritional Epidemiology. 3. New York: Oxford University Press; 2012. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.